Eli Lilly and Co (XSWX:LLY) Common Stock : CHF528 Mil (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Eli Lilly and Co Common Stock?

Eli Lilly and Co's quarterly common stock declined from Sep. 2023 (CHF534 Mil) to Dec. 2023 (CHF513 Mil) but then increased from Dec. 2023 (CHF513 Mil) to Mar. 2024 (CHF528 Mil).

Eli Lilly and Co's annual common stock increased from Dec. 2021 (CHF549 Mil) to Dec. 2022 (CHF553 Mil) but then declined from Dec. 2022 (CHF553 Mil) to Dec. 2023 (CHF513 Mil).

Eli Lilly and Co Common Stock Historical Data

The historical data trend for Eli Lilly and Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Common Stock Chart

Eli Lilly and Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

588.38

531.44

549.19

553.46

513.35

Eli Lilly and Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															549.28	534.48	534.00	513.35	528.01

Eli Lilly and Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Eli Lilly and Co (XSWX:LLY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (XSWX:LLY) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

LLY:USA LLY:Mexico 1LLY:Italy LLY:Germany LLY:Canada LILY34:Brazil LLYC:Austria LLY:Argentina

Address

Lilly Corporate Center, Indianapolis, IN, USA, 46285

Website

https://www.lilly.com

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.